Home
English
English
简体中文
Sign In
Help Desk
Journals
Advanced Search
BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Featured Articles
Journals
Submit a Manuscript
Articles Published Processes
Keyword:
Schizophrenia
Page 1 of 2 ( 87 items )
<<
1
2
>>
1
Safety and efficacy of different initial doses of lurasidone in the schizophrenia treatment: A multi-center, randomized, open-label study
9/26/2025 8:19:47 AM |
Browse: 292 |
Download: 106
2
Enhancing schizophrenia treatment efficacy: The combined impact of Yueju pill and olanzapine through quercetin target modulation
9/26/2025 8:19:28 AM |
Browse: 292 |
Download: 243
3
Neural correlates of aggression in schizophrenia: An event-related potential study using the competitive reaction time task
8/8/2025 10:23:17 AM |
Browse: 46 |
Download: 197
4
Cell-free DNA in extracellular vesicles: A candidate biomarker of schizophrenia
8/8/2025 10:23:11 AM |
Browse: 47 |
Download: 129
5
Interaction between the brain and multiple organ systems in schizophrenia
8/8/2025 10:23:10 AM |
Browse: 49 |
Download: 154
6
Gut-brain connection in schizophrenia: A narrative review
4/30/2025 8:58:20 AM |
Browse: 79 |
Download: 276
7
Effectiveness and safety of blonanserin monotherapy in first-episode schizophrenia with and without prominent negative symptoms: A prospective study
4/30/2025 8:58:18 AM |
Browse: 83 |
Download: 378
8
Therapeutic efficacy of transcranial direct current stimulation in treating auditory hallucinations in schizophrenia: A meta-analysis
2/26/2025 4:37:22 AM |
Browse: 72 |
Download: 424
9
Repetitive transcranial magnetic stimulation guided by event-related potential P300 application in schizophrenia
2/26/2025 4:37:20 AM |
Browse: 80 |
Download: 545
10
Metabolic pathway modulation by olanzapine: Multitarget approach for treating violent aggression in patients with schizophrenia
12/18/2024 8:36:43 AM |
Browse: 97 |
Download: 612
11
Brain-derived neurotrophic factor alterations and cognitive decline in schizophrenia: Implications for early intervention
12/18/2024 8:36:42 AM |
Browse: 95 |
Download: 458
12
Who can benefit more from its twelve-week treatment: A prospective cohort study of blonanserin for patients with schizophrenia
11/7/2024 8:33:31 AM |
Browse: 124 |
Download: 666
13
Advancement in utilization of magnetic resonance imaging and biomarkers in the understanding of schizophrenia
11/7/2024 5:10:58 AM |
Browse: 132 |
Download: 399
14
Expression level of myocardial enzymes in patients with schizophrenia: Predictive value in the occurrence of violence
9/11/2024 7:02:38 AM |
Browse: 130 |
Download: 653
15
Identification of male schizophrenia patients using brain morphology based on machine learning algorithms
6/19/2024 12:40:27 PM |
Browse: 177 |
Download: 929
16
Correlation between cognitive impairment and metabolic imbalance of gut microbiota in patients with schizophrenia
10/12/2023 4:44:25 AM |
Browse: 275 |
Download: 978
17
Effect of cognitive behavioral group therapy on rehabilitation of community patients with schizophrenia: A short-term randomized control trial
8/17/2023 7:08:15 AM |
Browse: 258 |
Download: 1061
18
Gastrointestinal and liver disease in patients with schizophrenia: A narrative review
10/12/2022 4:24:12 AM |
Browse: 489 |
Download: 1214
19
Delayed improvements in visual memory task performance among chronic schizophrenia patients after high-frequency repetitive transcranial magnetic stimulation
9/20/2022 11:01:13 AM |
Browse: 454 |
Download: 1485
20
Galectin-3 mediated risk of inflammation in stable schizophrenia, with only possible secondary consequences for cognition
9/20/2022 11:01:13 AM |
Browse: 453 |
Download: 1455
21
ABCB9 polymorphism (rs61955196) is associated with schizophrenia in Chinese Han population
7/19/2022 7:32:06 AM |
Browse: 490 |
Download: 1491
22
Social media and schizophrenia: An update on clinical applications
7/19/2022 7:32:06 AM |
Browse: 451 |
Download: 1160
23
Successful treatment of hyperglycemia with liraglutide in a hospitalized 27-year-old patient with schizophrenia: A case report
7/11/2022 8:36:01 AM |
Browse: 477 |
Download: 1209
24
Disrupted leptin-fatty acid biosynthesis is an early manifestation of metabolic abnormalities in schizophrenia
6/14/2022 7:57:01 AM |
Browse: 595 |
Download: 1170
25
Differences between delusional disorder and schizophrenia: A mini narrative review
5/18/2022 6:40:21 AM |
Browse: 603 |
Download: 1111
26
Abnormal synaptic plasticity and impaired cognition in schizophrenia
4/13/2022 7:47:57 AM |
Browse: 499 |
Download: 1352
27
Adult neural stem cells and schizophrenia
3/25/2022 7:41:02 AM |
Browse: 478 |
Download: 1257
28
Trajectories of response in schizophrenia-spectrum disorders: A one-year prospective cohort study of antipsychotic effectiveness
3/18/2022 12:26:44 PM |
Browse: 552 |
Download: 1679
29
Therapeutic use of melatonin in schizophrenia-more than meets the eye!
3/18/2022 12:26:44 PM |
Browse: 570 |
Download: 1462
30
Insights into myelin dysfunction in schizophrenia and bipolar disorder
2/17/2022 8:22:35 AM |
Browse: 529 |
Download: 1336
31
Prevalence and clinical characteristics of COVID-19 in inpatients with schizophrenia in Wuhan, China
1/18/2022 2:50:51 AM |
Browse: 652 |
Download: 1659
32
Psychological impact of the COVID-19 pandemic on individuals with serious mental disorders: A systematic review of the literature
12/15/2021 9:38:23 AM |
Browse: 545 |
Download: 1419
33
Differential aberrant connectivity of precuneus and anterior insula may underpin the diagnosis of schizophrenia and mood disorders
12/15/2021 9:38:23 AM |
Browse: 615 |
Download: 1514
34
Newer antipsychotics: Brexpiprazole, cariprazine, and lumateperone: A pledge or another unkept promise?
12/15/2021 9:38:23 AM |
Browse: 516 |
Download: 1133
35
Polyamines and polyamine-metabolizing enzymes in schizophrenia: Current knowledge and concepts of therapy
12/15/2021 9:38:23 AM |
Browse: 605 |
Download: 1372
36
Breast cancer in schizophrenia could be interleukin-33-mediated
11/17/2021 2:18:21 AM |
Browse: 576 |
Download: 1361
37
Therapeutic role of yoga on neuropsychological disorders
10/15/2021 9:56:18 AM |
Browse: 676 |
Download: 1664
38
Metabolic disturbances associated with antipsychotic drug treatment in patients with schizophrenia: State-of-the-art and future perspectives
10/15/2021 9:56:18 AM |
Browse: 650 |
Download: 1409
39
Galectin-3 possible involvement in antipsychotic-induced metabolic changes of schizophrenia: A minireview
10/13/2021 8:37:10 AM |
Browse: 593 |
Download: 1402
40
Therapeutic use of melatonin in schizophrenia: A systematic review
8/12/2021 8:46:10 AM |
Browse: 754 |
Download: 1618
41
Clozapine resistant schizophrenia: Newer avenues of management
8/12/2021 8:46:10 AM |
Browse: 613 |
Download: 1263
42
Novel approaches in schizophrenia-from risk factors and hypotheses to novel drug targets
7/15/2021 10:19:10 AM |
Browse: 881 |
Download: 1706
43
Implications from translational cross-validation of clinical assessment tools for diagnosis and treatment in psychiatry
5/13/2021 8:59:52 AM |
Browse: 645 |
Download: 1360
44
What gets in the way of social engagement in schizophrenia?
1/11/2021 11:00:37 AM |
Browse: 630 |
Download: 1788
45
How to construct neuroscience-informed psychiatric classification? Towards nomothetic networks psychiatry
1/11/2021 11:00:37 AM |
Browse: 767 |
Download: 1524
46
Dietary modification in the treatment of schizophrenia spectrum disorders: A systematic review
8/13/2020 5:58:52 AM |
Browse: 1002 |
Download: 1774
47
Suicide attempt using potassium tablets for congenital chloride diarrhea: A case report
4/24/2020 10:13:26 AM |
Browse: 865 |
Download: 1604
48
Prevalence and associated factors of suicide among hospitalized schizophrenic patients
2/26/2020 3:48:21 PM |
Browse: 945 |
Download: 2275
49
Do adjunctive art therapies reduce symptomatology in schizophrenia? A meta-analysis
12/10/2019 10:00:07 AM |
Browse: 1342 |
Download: 1969
50
Women who suffer from schizophrenia: Critical issues
11/9/2018 9:22:52 AM |
Browse: 1307 |
Download: 1733
Page 1 of 2 ( 87 items )
<<
1
2
>>
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345